Fractyl Health to Report Third Quarter 2025 Financial

BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D),…